Multiple Listed Companies Respond to "Universal Wonder Drug," Products Urgently Removed from Shelves

The so-called “universal miracle drug” exosomes exposed on CCTV’s 3.15 evening show were accused of illegally adding ingredients. In response, Jinbo Biotech issued a statement calling for regulatory authorities to conduct a thorough investigation. Noticing that several publicly listed companies are involved in the exosome field, Xinyang stated that related projects have been taken down; Kaineng Health’s subsidiary Laisen’s main business includes exosome therapy; Dongfulong has launched an industrialization solution for exosomes. A search for “exosomes” on the China Clinical Trial Registration Center revealed approximately 300 ongoing clinical trials, with over 70 registered in the past year. The diseases targeted are diverse, including sensitive skin conditions, arthritis, pneumonia, rhinitis, hair loss, dry eye syndrome, and facial rejuvenation. (Yicai Global)